nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0964	0.137	CbGbCtD
Nebivolol—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0906	0.129	CbGbCtD
Nebivolol—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0906	0.129	CbGbCtD
Nebivolol—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.082	0.116	CbGbCtD
Nebivolol—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.082	0.116	CbGbCtD
Nebivolol—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0708	0.1	CbGbCtD
Nebivolol—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0687	0.0974	CbGbCtD
Nebivolol—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0621	0.0881	CbGbCtD
Nebivolol—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0621	0.0881	CbGbCtD
Nebivolol—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000739	0.00251	CcSEcCtD
Nebivolol—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000738	0.0025	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000737	0.0025	CcSEcCtD
Nebivolol—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000733	0.00249	CcSEcCtD
Nebivolol—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000728	0.00247	CcSEcCtD
Nebivolol—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000727	0.00247	CcSEcCtD
Nebivolol—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000724	0.00246	CcSEcCtD
Nebivolol—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000723	0.00245	CcSEcCtD
Nebivolol—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000721	0.00245	CcSEcCtD
Nebivolol—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00072	0.00244	CcSEcCtD
Nebivolol—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.00072	0.00244	CcSEcCtD
Nebivolol—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000719	0.00244	CcSEcCtD
Nebivolol—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000717	0.00243	CcSEcCtD
Nebivolol—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000709	0.0024	CcSEcCtD
Nebivolol—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000708	0.0024	CcSEcCtD
Nebivolol—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000707	0.0024	CcSEcCtD
Nebivolol—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000706	0.0024	CcSEcCtD
Nebivolol—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000705	0.00239	CcSEcCtD
Nebivolol—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.000701	0.00238	CcSEcCtD
Nebivolol—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000701	0.00238	CcSEcCtD
Nebivolol—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000701	0.00238	CcSEcCtD
Nebivolol—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000701	0.00238	CcSEcCtD
Nebivolol—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.0007	0.00238	CcSEcCtD
Nebivolol—Shock—Indinavir—acquired immunodeficiency syndrome	0.000699	0.00237	CcSEcCtD
Nebivolol—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000699	0.00237	CcSEcCtD
Nebivolol—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000697	0.00237	CcSEcCtD
Nebivolol—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000697	0.00237	CcSEcCtD
Nebivolol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000696	0.00236	CcSEcCtD
Nebivolol—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000696	0.00236	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000696	0.00236	CcSEcCtD
Nebivolol—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000695	0.00236	CcSEcCtD
Nebivolol—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000693	0.00235	CcSEcCtD
Nebivolol—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000692	0.00235	CcSEcCtD
Nebivolol—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000691	0.00235	CcSEcCtD
Nebivolol—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000691	0.00234	CcSEcCtD
Nebivolol—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000688	0.00234	CcSEcCtD
Nebivolol—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000686	0.00233	CcSEcCtD
Nebivolol—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000685	0.00232	CcSEcCtD
Nebivolol—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000682	0.00231	CcSEcCtD
Nebivolol—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00068	0.00231	CcSEcCtD
Nebivolol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000671	0.00228	CcSEcCtD
Nebivolol—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00067	0.00227	CcSEcCtD
Nebivolol—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000669	0.00227	CcSEcCtD
Nebivolol—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000661	0.00224	CcSEcCtD
Nebivolol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00066	0.00224	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00066	0.00224	CcSEcCtD
Nebivolol—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000659	0.00224	CcSEcCtD
Nebivolol—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000659	0.00223	CcSEcCtD
Nebivolol—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000658	0.00223	CcSEcCtD
Nebivolol—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000654	0.00222	CcSEcCtD
Nebivolol—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000654	0.00222	CcSEcCtD
Nebivolol—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000653	0.00222	CcSEcCtD
Nebivolol—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000652	0.00221	CcSEcCtD
Nebivolol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00065	0.00221	CcSEcCtD
Nebivolol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000648	0.0022	CcSEcCtD
Nebivolol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000644	0.00219	CcSEcCtD
Nebivolol—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000644	0.00219	CcSEcCtD
Nebivolol—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000643	0.00218	CcSEcCtD
Nebivolol—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00064	0.00217	CcSEcCtD
Nebivolol—Rash—Didanosine—acquired immunodeficiency syndrome	0.000639	0.00217	CcSEcCtD
Nebivolol—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000638	0.00217	CcSEcCtD
Nebivolol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000638	0.00217	CcSEcCtD
Nebivolol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000638	0.00217	CcSEcCtD
Nebivolol—Headache—Didanosine—acquired immunodeficiency syndrome	0.000635	0.00215	CcSEcCtD
Nebivolol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000634	0.00215	CcSEcCtD
Nebivolol—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000633	0.00215	CcSEcCtD
Nebivolol—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000632	0.00215	CcSEcCtD
Nebivolol—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000632	0.00214	CcSEcCtD
Nebivolol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000631	0.00214	CcSEcCtD
Nebivolol—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00063	0.00214	CcSEcCtD
Nebivolol—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000629	0.00213	CcSEcCtD
Nebivolol—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000629	0.00213	CcSEcCtD
Nebivolol—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000625	0.00212	CcSEcCtD
Nebivolol—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000624	0.00212	CcSEcCtD
Nebivolol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000624	0.00212	CcSEcCtD
Nebivolol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000623	0.00211	CcSEcCtD
Nebivolol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000622	0.00211	CcSEcCtD
Nebivolol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000622	0.00211	CcSEcCtD
Nebivolol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00062	0.0021	CcSEcCtD
Nebivolol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000616	0.00209	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000616	0.00209	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000614	0.00208	CcSEcCtD
Nebivolol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000613	0.00208	CcSEcCtD
Nebivolol—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000613	0.00208	CcSEcCtD
Nebivolol—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000611	0.00207	CcSEcCtD
Nebivolol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000608	0.00206	CcSEcCtD
Nebivolol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000607	0.00206	CcSEcCtD
Nebivolol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000604	0.00205	CcSEcCtD
Nebivolol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000604	0.00205	CcSEcCtD
Nebivolol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000603	0.00205	CcSEcCtD
Nebivolol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000602	0.00204	CcSEcCtD
Nebivolol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000602	0.00204	CcSEcCtD
Nebivolol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000601	0.00204	CcSEcCtD
Nebivolol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.0006	0.00203	CcSEcCtD
Nebivolol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000599	0.00203	CcSEcCtD
Nebivolol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000597	0.00203	CcSEcCtD
Nebivolol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000597	0.00202	CcSEcCtD
Nebivolol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000593	0.00201	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000593	0.00201	CcSEcCtD
Nebivolol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000588	0.00199	CcSEcCtD
Nebivolol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000585	0.00198	CcSEcCtD
Nebivolol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000583	0.00198	CcSEcCtD
Nebivolol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000583	0.00198	CcSEcCtD
Nebivolol—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000582	0.00197	CcSEcCtD
Nebivolol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000582	0.00197	CcSEcCtD
Nebivolol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000581	0.00197	CcSEcCtD
Nebivolol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000581	0.00197	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00058	0.00197	CcSEcCtD
Nebivolol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000579	0.00197	CcSEcCtD
Nebivolol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000579	0.00196	CcSEcCtD
Nebivolol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000577	0.00196	CcSEcCtD
Nebivolol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000577	0.00196	CcSEcCtD
Nebivolol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000574	0.00195	CcSEcCtD
Nebivolol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000574	0.00195	CcSEcCtD
Nebivolol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000573	0.00194	CcSEcCtD
Nebivolol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000573	0.00194	CcSEcCtD
Nebivolol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000571	0.00194	CcSEcCtD
Nebivolol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000571	0.00194	CcSEcCtD
Nebivolol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000569	0.00193	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000565	0.00192	CcSEcCtD
Nebivolol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000565	0.00192	CcSEcCtD
Nebivolol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000563	0.00191	CcSEcCtD
Nebivolol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000562	0.00191	CcSEcCtD
Nebivolol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000561	0.0019	CcSEcCtD
Nebivolol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000561	0.0019	CcSEcCtD
Nebivolol—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00056	0.0019	CcSEcCtD
Nebivolol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000559	0.0019	CcSEcCtD
Nebivolol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000556	0.00189	CcSEcCtD
Nebivolol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000556	0.00189	CcSEcCtD
Nebivolol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000556	0.00189	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000555	0.00188	CcSEcCtD
Nebivolol—Rash—Stavudine—acquired immunodeficiency syndrome	0.000555	0.00188	CcSEcCtD
Nebivolol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000554	0.00188	CcSEcCtD
Nebivolol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000554	0.00188	CcSEcCtD
Nebivolol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000553	0.00188	CcSEcCtD
Nebivolol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000551	0.00187	CcSEcCtD
Nebivolol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000551	0.00187	CcSEcCtD
Nebivolol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000549	0.00186	CcSEcCtD
Nebivolol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000548	0.00186	CcSEcCtD
Nebivolol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000546	0.00185	CcSEcCtD
Nebivolol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000546	0.00185	CcSEcCtD
Nebivolol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000543	0.00184	CcSEcCtD
Nebivolol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000541	0.00184	CcSEcCtD
Nebivolol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000541	0.00183	CcSEcCtD
Nebivolol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000538	0.00182	CcSEcCtD
Nebivolol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000537	0.00182	CcSEcCtD
Nebivolol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000535	0.00182	CcSEcCtD
Nebivolol—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000534	0.00181	CcSEcCtD
Nebivolol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000534	0.00181	CcSEcCtD
Nebivolol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000534	0.00181	CcSEcCtD
Nebivolol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000531	0.0018	CcSEcCtD
Nebivolol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00053	0.0018	CcSEcCtD
Nebivolol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00053	0.0018	CcSEcCtD
Nebivolol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000528	0.00179	CcSEcCtD
Nebivolol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000526	0.00178	CcSEcCtD
Nebivolol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000524	0.00178	CcSEcCtD
Nebivolol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000524	0.00178	CcSEcCtD
Nebivolol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000523	0.00177	CcSEcCtD
Nebivolol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000522	0.00177	CcSEcCtD
Nebivolol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000517	0.00176	CcSEcCtD
Nebivolol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000515	0.00175	CcSEcCtD
Nebivolol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000514	0.00174	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000513	0.00174	CcSEcCtD
Nebivolol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000512	0.00174	CcSEcCtD
Nebivolol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000511	0.00173	CcSEcCtD
Nebivolol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00051	0.00173	CcSEcCtD
Nebivolol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00051	0.00173	CcSEcCtD
Nebivolol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000509	0.00173	CcSEcCtD
Nebivolol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000508	0.00172	CcSEcCtD
Nebivolol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000506	0.00172	CcSEcCtD
Nebivolol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000503	0.00171	CcSEcCtD
Nebivolol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000495	0.00168	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000494	0.00168	CcSEcCtD
Nebivolol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000494	0.00167	CcSEcCtD
Nebivolol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000493	0.00167	CcSEcCtD
Nebivolol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00049	0.00166	CcSEcCtD
Nebivolol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000487	0.00165	CcSEcCtD
Nebivolol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000486	0.00165	CcSEcCtD
Nebivolol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000486	0.00165	CcSEcCtD
Nebivolol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000486	0.00165	CcSEcCtD
Nebivolol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000485	0.00165	CcSEcCtD
Nebivolol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000482	0.00164	CcSEcCtD
Nebivolol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000482	0.00164	CcSEcCtD
Nebivolol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000482	0.00163	CcSEcCtD
Nebivolol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000479	0.00162	CcSEcCtD
Nebivolol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000475	0.00161	CcSEcCtD
Nebivolol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000474	0.00161	CcSEcCtD
Nebivolol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000472	0.0016	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000471	0.0016	CcSEcCtD
Nebivolol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00047	0.0016	CcSEcCtD
Nebivolol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00047	0.0016	CcSEcCtD
Nebivolol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00047	0.00159	CcSEcCtD
Nebivolol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000468	0.00159	CcSEcCtD
Nebivolol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000461	0.00156	CcSEcCtD
Nebivolol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00046	0.00156	CcSEcCtD
Nebivolol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000455	0.00154	CcSEcCtD
Nebivolol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000454	0.00154	CcSEcCtD
Nebivolol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000454	0.00154	CcSEcCtD
Nebivolol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000452	0.00153	CcSEcCtD
Nebivolol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000452	0.00153	CcSEcCtD
Nebivolol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000448	0.00152	CcSEcCtD
Nebivolol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000448	0.00152	CcSEcCtD
Nebivolol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000446	0.00151	CcSEcCtD
Nebivolol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000445	0.00151	CcSEcCtD
Nebivolol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000444	0.00151	CcSEcCtD
Nebivolol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00044	0.00149	CcSEcCtD
Nebivolol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000438	0.00149	CcSEcCtD
Nebivolol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000434	0.00147	CcSEcCtD
Nebivolol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000431	0.00146	CcSEcCtD
Nebivolol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000427	0.00145	CcSEcCtD
Nebivolol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000426	0.00145	CcSEcCtD
Nebivolol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00144	CcSEcCtD
Nebivolol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000424	0.00144	CcSEcCtD
Nebivolol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000423	0.00144	CcSEcCtD
Nebivolol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000422	0.00143	CcSEcCtD
Nebivolol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000421	0.00143	CcSEcCtD
Nebivolol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000421	0.00143	CcSEcCtD
Nebivolol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00042	0.00143	CcSEcCtD
Nebivolol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00041	0.00139	CcSEcCtD
Nebivolol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000409	0.00139	CcSEcCtD
Nebivolol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.00138	CcSEcCtD
Nebivolol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000405	0.00137	CcSEcCtD
Nebivolol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000405	0.00137	CcSEcCtD
Nebivolol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000405	0.00137	CcSEcCtD
Nebivolol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000403	0.00137	CcSEcCtD
Nebivolol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000402	0.00136	CcSEcCtD
Nebivolol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000399	0.00135	CcSEcCtD
Nebivolol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.00133	CcSEcCtD
Nebivolol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000392	0.00133	CcSEcCtD
Nebivolol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000391	0.00133	CcSEcCtD
Nebivolol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000386	0.00131	CcSEcCtD
Nebivolol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000382	0.0013	CcSEcCtD
Nebivolol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00128	CcSEcCtD
Nebivolol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000378	0.00128	CcSEcCtD
Nebivolol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000375	0.00127	CcSEcCtD
Nebivolol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000374	0.00127	CcSEcCtD
Nebivolol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000373	0.00127	CcSEcCtD
Nebivolol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000372	0.00126	CcSEcCtD
Nebivolol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000364	0.00123	CcSEcCtD
Nebivolol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00122	CcSEcCtD
Nebivolol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000361	0.00122	CcSEcCtD
Nebivolol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.00122	CcSEcCtD
Nebivolol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000358	0.00122	CcSEcCtD
Nebivolol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000353	0.0012	CcSEcCtD
Nebivolol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000347	0.00118	CcSEcCtD
Nebivolol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000344	0.00117	CcSEcCtD
Nebivolol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000344	0.00117	CcSEcCtD
Nebivolol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000342	0.00116	CcSEcCtD
Nebivolol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00034	0.00115	CcSEcCtD
Nebivolol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.0011	CcSEcCtD
